Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DENTSPLY SIRONA Inc.XRAY · Entity 4448 | Director | April 12, 2024 | April 15, 2024 |
| Gen Digital Inc.GEN · Entity 2098 | Director | September 09, 2026 | September 11, 2026 |
| LAM RESEARCH CORPLRCX · Entity 1467 | Director | June 12, 2026 | June 15, 2026 |
| MACERICH COMAC · Entity 3712 | Director | May 30, 2024 | June 04, 2024 |
| Nutanix, Inc.NTNX · Entity 3296 | Director | December 12, 2025 | December 17, 2025 |
| Option Care Health, Inc.OPCH · Entity 4126 | Director | May 20, 2026 | May 22, 2026 |
| VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875 | Director | January 29, 2009 | January 30, 2009 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DENTSPLY SIRONA Inc.
Report date April 12, 2024 · Filed April 15, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 53,372.146 |
Reported balance
After 2024-04-12 transaction · row 2
1 source rowRow 2 · 2024-04-12 · Grant · Acquired 72.546 · Balance 53,372.146 F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. |
| Phantom Stock (Directors' Deferred Compensation) DDCSEC Table II · derivative / convertible security | Direct | 1,543.4018 |
Reported balance
After 2024-04-12 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-04-12 · Grant · Acquired 7.8111 · Balance 1,543.4018 F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3: Comprised of phantom stock acquired as a result of accrued dividends. |
| Common StockSEC Table I · non-derivative | IndirectBy The Brandt Family Trust U/a Dtd 06/09/2006 | 5,400 |
Reported balance
Holding disclosure · report date 2024-04-12 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,400 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director.
F3: Comprised of phantom stock acquired as a result of accrued dividends.
Gen Digital Inc.
Report date September 09, 2026 · Filed September 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,072 |
Ending reported balance
After 2026-09-09 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-09 · Grant · Acquired 9,072 · Balance 17,894 F1: Annual non-employee director equity award. The RSUs will vest 100% on the earlier of September 9, 2027, or the next annual meeting, and subject to service through the respective vesting date. Row 2 · 2026-09-09 · Gift · Disposed 8,822 · Balance 9,072 F2: Stock transfer to family trust over which the reporting person has voting power. |
| Common StockSEC Table I · non-derivative | IndirectThe Brandt Family Trust | 78,506 |
Reported balance
After 2026-09-09 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-09-09 · Gift · Acquired 8,822 · Balance 78,506 |
Filing footnotes · ownership attribution and instrument terms
F1: Annual non-employee director equity award. The RSUs will vest 100% on the earlier of September 9, 2027, or the next annual meeting, and subject to service through the respective vesting date.
F2: Stock transfer to family trust over which the reporting person has voting power.
LAM RESEARCH CORP
Report date June 12, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 144,705 |
Last balance in matching sequence
After 2026-06-12 transaction · row 17
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
17 source rowsRow 1 · 2026-06-12 · Sale · Disposed 300 · Balance 198,905 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $355.39 to $356.02, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 2 · 2026-06-12 · Sale · Disposed 1,393 · Balance 197,512 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $356.685 to $357.67, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 3 · 2026-06-12 · Sale · Disposed 1,100 · Balance 196,412 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F5: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $357.68 to $358.35, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 4 · 2026-06-12 · Sale · Disposed 3,828 · Balance 192,584 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F6: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $358.73 to $359.54, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 5 · 2026-06-12 · Sale · Disposed 1,906 · Balance 190,678 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F7: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $359.84 to $360.79, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 6 · 2026-06-12 · Sale · Disposed 819 · Balance 189,859 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F8: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $360.85 to $361.83, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 7 · 2026-06-12 · Sale · Disposed 2,708 · Balance 187,151 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F9: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $361.87 to $362.82, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 8 · 2026-06-12 · Sale · Disposed 2,345 · Balance 184,806 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F10: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $363.77, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 9 · 2026-06-12 · Sale · Disposed 2,300 · Balance 182,506 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F11: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $364.85, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 10 · 2026-06-12 · Sale · Disposed 1,200 · Balance 181,306 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F12: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $364.98 to $365.67, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 11 · 2026-06-12 · Sale · Disposed 5,803 · Balance 175,503 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F13: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $366.56 to $367.55, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 12 · 2026-06-12 · Sale · Disposed 4,030 · Balance 171,473 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F14: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $367.62 to $368.49, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 13 · 2026-06-12 · Sale · Disposed 4,198 · Balance 167,275 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F15: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.70 to $369.64, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 14 · 2026-06-12 · Sale · Disposed 5,037 · Balance 162,238 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F16: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $369.70 to $370.69, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 15 · 2026-06-12 · Sale · Disposed 8,233 · Balance 154,005 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F17: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $370.70 to $371.59, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 16 · 2026-06-12 · Sale · Disposed 7,700 · Balance 146,305 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F18: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $371.77 to $372.76, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 17 · 2026-06-12 · Sale · Disposed 1,600 · Balance 144,705 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F19: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $372.79 to $373.36, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $355.39 to $356.02, inclusive
F3: The amount reported includes shares subject to unvested restricted stock units.
F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $356.685 to $357.67, inclusive
F5: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $357.68 to $358.35, inclusive
F6: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $358.73 to $359.54, inclusive
F7: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $359.84 to $360.79, inclusive
F8: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $360.85 to $361.83, inclusive
F9: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $361.87 to $362.82, inclusive
F10: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $363.77, inclusive
F11: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $364.85, inclusive
F12: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $364.98 to $365.67, inclusive
F13: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $366.56 to $367.55, inclusive
F14: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $367.62 to $368.49, inclusive
F15: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.70 to $369.64, inclusive
F16: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $369.70 to $370.69, inclusive
F17: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $370.70 to $371.59, inclusive
F18: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $371.77 to $372.76, inclusive
F19: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $372.79 to $373.36, inclusive
MACERICH CO
Report date May 30, 2024 · Filed June 04, 2024 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 62,978 |
Reported balance
Holding disclosure · report date 2024-05-30 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance 62,978 |
Nutanix, Inc.
Report date December 12, 2025 · Filed December 17, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 6,698 |
Reported balance
After 2025-12-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-12-12 · Grant · Acquired 4,588 · Balance 6,698 F1: Reflects shares that the Reporting Person will receive upon the settlement of restricted stock units ("RSUs"), which will vest in full on the earlier of (i) the day prior to the next annual meeting of the Issuer's shareholders held after the date of grant or (ii) the one-year anniversary of the date of grant, in each case, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. F2: The amount reported includes 4,588 unvested RSUs, which are issuable into shares of the Issuer's Class A common stock upon vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares that the Reporting Person will receive upon the settlement of restricted stock units ("RSUs"), which will vest in full on the earlier of (i) the day prior to the next annual meeting of the Issuer's shareholders held after the date of grant or (ii) the one-year anniversary of the date of grant, in each case, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock.
F2: The amount reported includes 4,588 unvested RSUs, which are issuable into shares of the Issuer's Class A common stock upon vesting.
Option Care Health, Inc.
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,999 |
Ending reported balance
After 2026-05-20 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-20 · Grant · Acquired 8,997 · Balance 19,356 F1: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026. Row 2 · 2026-05-20 · Grant · Acquired 2,643 · Balance 21,999 F2: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.
F2: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.
VERTEX PHARMACEUTICALS INC / MA
Report date January 29, 2009 · Filed January 30, 2009
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2009-01-29 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2009-01-29 · Exercise / conversion · Acquired 20,000 · Balance 20,000 Row 2 · 2009-01-29 · Exercise / conversion · Acquired 7,500 · Balance 27,500 Row 3 · 2009-01-29 · Sale · Disposed 27,500 · Balance 0 F1: Transaction made pursuant to Mr. Brandt's company approved trading plan under Rule 10b5-1. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $13.22 · Expires 2013-05-20 | Direct | 0 |
Reported balance
After 2009-01-29 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2009-01-29 · Exercise / conversion · Disposed 20,000 · Balance 0 F2: Fully vested. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $9.09 · Expires 2015-05-31 | Direct | 0 |
Reported balance
After 2009-01-29 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2009-01-29 · Exercise / conversion · Disposed 7,500 · Balance 0 F2: Fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction made pursuant to Mr. Brandt's company approved trading plan under Rule 10b5-1.
F2: Fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 08, 2022 Filed Apr 11, 2022 21:10 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative | 3.878 | $48.08 | $186.45 |
DisclosureSEC source: 0001127602-22-011833 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,495.6027 Underlying: Common Stock · 3.878 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| April 08, 2022 Filed Apr 11, 2022 21:10 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 28.09 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-011833 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,154.904 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| January 14, 2022 Filed Jan 20, 2022 02:41 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation Plan) DDC · Derivative | 3.0594 | $53.52 | $163.74 |
DisclosureSEC source: 0001306483-22-000015 · primary_doc.xml · derivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,491.7247 Underlying: Common Stock · 3.0594 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| January 14, 2022 Filed Jan 20, 2022 02:41 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 21.974 | $0.00 | $0.00 |
DisclosureSEC source: 0001306483-22-000015 · primary_doc.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,126,814 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject o the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 21:17 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 377 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-21-000189 · wf-form4_163709723109929.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,852 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 08, 2021 Filed Oct 12, 2021 20:14 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative | 2.796 | $58.46 | $163.45 |
DisclosureSEC source: 0001127602-21-026947 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,488.6653 Underlying: Common Stock · 2.796 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| October 08, 2021 Filed Oct 12, 2021 20:14 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 20.391 | $60.01 | $1,223.66 |
DisclosureSEC source: 0001127602-21-026947 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,104.84 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 09, 2021 Filed Jul 13, 2021 20:39 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative | 2.6077 | $2.00 | $5.22 |
DisclosureSEC source: 0001127602-21-021879 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,485.8693 Underlying: Common Stock · 2.6077 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| July 09, 2021 Filed Jul 13, 2021 20:39 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 19.033 | $64.18 | $1,221.54 |
DisclosureSEC source: 0001127602-21-021879 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,084.449 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 23:29 UTC | MACERICH CO MAC · Entity 3712 | GrantCommon Stock | 8,485 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037434 · doc4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,450 F1 · shares: Non-cash compensation - Award of restricted stock units under The Macerich Company 2003 Equity Incentive Plan. The restricted stock units vest one year after the award. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 20:28 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 4,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018502 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,065.416 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 13, 2021 Filed May 14, 2021 20:33 UTC | Gen Digital Inc. NLOK · Entity 2098 | GrantCommon Stock | 1,970 | $25.37 | $49,978.90 |
DisclosureSEC source: 0001209191-21-032741 · doc4.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Brandt Family Trust Disclosed balance after: 29,326 F2 · shares: Shares issued pursuant to 2000 Director Equity Incentive Plan, as amended. Read SEC document |
| May 13, 2021 Filed May 14, 2021 20:33 UTC | Gen Digital Inc. NLOK · Entity 2098 | GrantCommon Stock | 10,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032741 · doc4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Brandt Family Trust Disclosed balance after: 27,356 F1 · shares: In connection with the reporting person's service as a non-employee director of the Issuer, pursuant to the non-employee director grant policy,such reporting person has been granted restricted stock units. 100% of the restricted stock units vest on grant date. Read SEC document |
| April 09, 2021 Filed Apr 12, 2021 21:10 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative | 2.3079 | $64.17 | $148.10 |
DisclosureSEC source: 0001127602-21-013640 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,483.2616 Underlying: Common Stock · 2.3079 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| April 09, 2021 Filed Apr 12, 2021 21:10 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 22.484 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-013640 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,553.416 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 20:20 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,600 | $0.00 Strike: $38.57 | $0.00 |
DisclosureSEC source: 0001127602-21-011529 · form4.xml · derivative · entry 4 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,600 shares Expires 2021-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 20:20 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | SaleCommon Stock | 7,600 | $63.21 | $480,373.20 |
DisclosureSEC source: 0001127602-21-011529 · form4.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,530.932 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.92 to 63.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 20:20 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 7,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-011529 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,130.932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 21:16 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative | 2.5128 | $58.84 | $147.85 |
DisclosureSEC source: 0001127602-21-001484 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,480.9537 Underlying: Common Stock · 2.5128 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 21:16 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 26.538 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-001484 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,530.932 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| November 06, 2020 Filed Nov 10, 2020 19:50 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 510 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-20-000185 · wf-form4_160503782526062.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,475 F1 · balance_after: The amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 19:08 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative | 3.2061 | $46.01 | $147.51 |
DisclosureSEC source: 0001127602-20-026839 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,478.4409 Underlying: Common Stock · 3.2061 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 19:08 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 36.634 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026839 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,504.394 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 10, 2020 Filed Jul 14, 2020 20:06 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative | 3.5421 | $41.55 | $147.17 |
DisclosureSEC source: 0001127602-20-021485 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,475.2348 Underlying: Common Stock · 3.5421 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| July 10, 2020 Filed Jul 14, 2020 20:06 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 31.745 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-021485 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,467.76 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| June 18, 2020 Filed Jun 22, 2020 22:53 UTC | MACERICH CO MAC · Entity 3712 | GrantCommon Stock | 14,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-038309 · doc4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,965 F1 · shares: Non-cash compensation - Award of restricted stock units under The Macerich Company 2003 Equity Incentive Plan. The restricted stock units vest one year after the award. F2 · balance_after: Includes 104 shares acquired as part of the Company's quarterly dividend paid on June 3, 2020. Read SEC document |
| May 21, 2020 Filed May 22, 2020 20:14 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 7,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-017748 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,436.015 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 19, 2020 Filed May 20, 2020 20:53 UTC | Gen Digital Inc. NLOK · Entity 2098 | GrantCommon Stock | 2,471 | $20.23 | $49,988.33 |
DisclosureSEC source: 0001209191-20-030919 · doc4.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Brandt Family Trust Disclosed balance after: 17,108 F2 · shares: Shares issued pursuant to 2000 Director Equity Incentive Plan, as amended. Read SEC document |
| May 19, 2020 Filed May 20, 2020 20:53 UTC | Gen Digital Inc. NLOK · Entity 2098 | GrantCommon Stock | 12,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030919 · doc4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Brandt Family Trust Disclosed balance after: 14,637 F1 · shares: In connection with the reporting person's service as a non-employee director of the Issuer, pursuant to the non-employee director grant policy,such reporting person has been granted restricted stock units. 100% of the restricted stock units vest on grant date. Read SEC document |
| May 04, 2020 Filed May 5, 2020 20:18 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,900 | $0.00 Strike: $35.91 | $0.00 |
DisclosureSEC source: 0001127602-20-015418 · form4.xml · derivative · entry 4 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,900 shares Expires 2020-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| May 04, 2020 Filed May 5, 2020 20:18 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | SaleCommon Stock | 8,900 | $39.47 | $351,283.00 |
DisclosureSEC source: 0001127602-20-015418 · form4.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,287.015 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.17 to $39.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 04, 2020 Filed May 5, 2020 20:18 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 8,900 | $35.91 | $319,599.00 |
DisclosureSEC source: 0001127602-20-015418 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,187.015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 13, 2020 Filed Apr 14, 2020 20:02 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative | 3.6465 | $40.26 | $146.81 |
DisclosureSEC source: 0001127602-20-013683 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,471.6927 Underlying: Common Stock · 3.6465 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F3 · price: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| April 10, 2020 Filed Apr 14, 2020 20:02 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 34.008 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-013683 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,287.015 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 21:31 UTC | Gen Digital Inc. NLOK · Entity 2098 | GrantCommon Stock | 274 | $19.13 | $5,241.62 |
DisclosureSEC source: 0001209191-20-016616 · doc4.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Brandt Family Trust Disclosed balance after: 1,785 F2 · shares: Shares issued pursuant to 2000 Director Equity Incentive Plan, as amended. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 21:31 UTC | Gen Digital Inc. NLOK · Entity 2098 | GrantCommon Stock | 1,511 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-016616 · doc4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Brandt Family Trust Disclosed balance after: 1,511 F1 · shares: In connection with the reporting person's service as a non-employee director of the Issuer, pursuant to the non-employee director grant policy, such reporting person has been granted restricted stock units. 100% of the restricted stock units vest on grant date. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 21:18 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative | 2.5346 | $57.82 | $146.55 |
DisclosureSEC source: 0001127602-20-001542 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,468.0462 Underlying: Common Stock · 2.5346 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 21:18 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 22.654 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-001542 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,253.007 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:13 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 770 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-19-000184 · wf-form4_157359317765948.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,965 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| October 11, 2019 Filed Oct 16, 2019 20:06 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 24.305 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030601 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,230.353 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 20:25 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative | 2.2491 | $56.82 | $127.80 |
DisclosureSEC source: 0001127602-19-024619 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,462.8259 Underlying: Common Stock · 2.2491 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 20:25 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 19.239 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-024619 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,206.048 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 23:18 UTC | MACERICH CO MAC · Entity 3712 | GrantCommon Stock | 3,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-036256 · doc4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,330 F1 · kind: Non-cash compensation - Award of restricted stock units under The Macerich Company 2003 Equity Incentive Plan ("2003 Plan"). The restricted stock units vest one year after the award. F1 · price: Non-cash compensation - Award of restricted stock units under The Macerich Company 2003 Equity Incentive Plan ("2003 Plan"). The restricted stock units vest one year after the award. Read SEC document |
| May 24, 2019 Filed May 29, 2019 20:46 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 6,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020152 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,186.809 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 03, 2019 Filed May 6, 2019 20:08 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,160 | $0.00 Strike: $29.70 | $0.00 |
DisclosureSEC source: 0001127602-19-017429 · form4.xml · derivative · entry 4 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,160 shares Expires 2019-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| May 03, 2019 Filed May 6, 2019 20:08 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | SaleCommon Stock | 9,160 | $53.45 | $489,602.00 |
DisclosureSEC source: 0001127602-19-017429 · form4.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,842.809 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person. Read SEC document |
| May 03, 2019 Filed May 6, 2019 20:08 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 9,160 | $29.70 | $272,052.00 |
DisclosureSEC source: 0001127602-19-017429 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,002.809 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2019 Filed May 1, 2019 21:06 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GiftCommon Stock | 2,595 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-19-000081 · wf-form4_155674478216306.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,195 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| April 12, 2019 Filed Apr 15, 2019 20:07 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) · Derivative | 2.5042 | $50.95 | $127.59 |
DisclosureSEC source: 0001127602-19-015434 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,460.5768 Underlying: Common Stock · 2.5042 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| April 12, 2019 Filed Apr 15, 2019 20:07 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 16.033 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-015434 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,842.809 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.